Oramed, Ltd.

13 clinical trials · Sponsor

Record	Firm	Date
A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) (NCT04616014)	Oramed, Ltd.	2021-03-01
Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus (NCT04606576)	Oramed, Ltd.	2020-12-15
A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) (NCT04618744)	Oramed, Ltd.	2020-11-24
A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus (NCT04564846)	Oramed, Ltd.	2020-11-23
A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes (NCT04150107)	Oramed, Ltd.	2019-10-17
A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) (NCT02653300)	Oramed, Ltd.	2018-09-20
A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus (NCT03467932)	Oramed, Ltd.	2018-05-29

Every clearance here is in the API, with alerts when new ones post.